MENU
Vertex Pharmaceuticals (VRTX) Ownership - Who owns Vertex Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
50 Northern Avenue
Phone
+1 617 341-6100
Employees
5400
Web
https://www.vrtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
122.53B
P/E Ratio
32.76
Total Cash
5.8B
Projected Growth
0.58
Total Debt
933.4M
Revenue
10.34B
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash/Share
22.45
Total Debt/Equity
43.97
Revenue/Share
39.85 USD as % of share price
Fundamentals
VRTX
Capitalization
123B
P/E Ratio
32.76
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash
5.8B
Total Cash/Share
22.45
Total Debt
933M
Total Debt/Equity
43.97
Projected Growth (PEG Ratio)
0.58
Revenue/Share (as % of the share price)
39.85%
Revenue
10.3B
ROE
N/A
Book Value
14.8B
P/B Ratio
8.36
Cash Flow
N/A
Earnings
-1.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.6M
Current Ratio
2.52
Current Revenue Per Employee
489925.94
Dividends Per Share - Security
N/A
EBITDA
465M
Float
N/A
Float - Current
N/A
Gross Income Margin
85.94
Revenue To Assets
-2.42
Shares Held By Institutions
433B
Shares Outstanding - Current
258M
Total Liabilities
5.36B
Total Volume MTD
N/A
Value
-1
Gain YTD
15.702
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company that discovers and develops novel, small molecule pharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
50 Northern Avenue
Phone
+1 617 341-6100
Employees
5400
Web
https://www.vrtx.com